- Next Generation Technology is World's Most Affordable Flatbed, UV Inkjet Printer -

SOUTH WINDSOR, Conn., Jan. 7 /PRNewswire-FirstCall/ -- Gerber Scientific, Inc. (NYSE: GRB) announced today that it will debut its next generation inkjet technology, the Solara ionV later this week and will begin shipping by month end. While offering similar benefits as the Solara ionX, the latest generation of flatbed UV inkjet printer will be offered in a significantly more affordable package. Capitalizing on the tremendous success of Gerber's innovative UV inkjet printing technology that utilizes GerberCAT(TM) cationic UV inks and Gerber's patent-pending Cold Fire Cure(TM) process, the Gerber Solara ionV offers a price point that allows almost any size print shop to take advantage of its versatility and superior performance.

"We're very excited about the introduction of our latest generation of cutting edge flatbed UV inkjet printers, which allows us to offer this advanced technology to a broader range of sign shops and printers -- and lets them take advantage of the versatility and exceptional performance of the ionV," said Marc Giles, Gerber Scientific President and Chief Executive Officer. "While as much as 30% less expensive than the ionX, there isn't a better built, more feature rich flatbed printer in this price range in the marketplace today."

For more information about this new product, please visit: www.gspinc.com.

About Gerber Scientific, Inc.

Gerber Scientific, Inc. (http://www.gerberscientific.com) is a leading international supplier of sophisticated automated manufacturing systems for sign making, specialty graphics and packaging, apparel and flexible materials, and ophthalmic lens processing. Headquartered in South Windsor, Connecticut, the Company operates through four primary businesses: Gerber Scientific Products, Spandex, Gerber Technology and Gerber Coburn.

Cautionary Note Concerning Factors That May Affect Future Results

This news release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements contained in this news release regarding product launches and benefits are forward-looking statements that involve risks and uncertainties. For information identifying other important economic, political, regulatory, legal, technological, competitive and other uncertainties, readers are referred to the Company's filings with the Securities and Exchange Commission, including but not limited to, the information included in Gerber Scientific's Annual Report on Form 10-K for the fiscal year ended April 30, 2008 under the headings "Business," "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations - Cautionary Note Concerning Factors That May Influence Future Results," as well as information included in subsequently filed Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, which outline certain important risks regarding the Company's forward-looking statements. These risks include, but are not limited to, delays in the Company's new product development and commercialization, intense competition in markets for each of the Company's operating segments, rapid technological advances, availability and cost of raw materials, volatility in foreign currency exchange rates and fluctuations in interest rates. Actual future results or events may differ materially from these forward-looking statements. The Company expressly disclaims any obligation to update any of these forward-looking statements, except as required by law.

SOURCE Gerber Scientific, Inc.